Christie Thomas

961 total citations · 1 hit paper
12 papers, 749 citations indexed

About

Christie Thomas is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christie Thomas has authored 12 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Public Health, Environmental and Occupational Health and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christie Thomas's work include Substance Abuse Treatment and Outcomes (9 papers), Opioid Use Disorder Treatment (9 papers) and Prenatal Substance Exposure Effects (4 papers). Christie Thomas is often cited by papers focused on Substance Abuse Treatment and Outcomes (9 papers), Opioid Use Disorder Treatment (9 papers) and Prenatal Substance Exposure Effects (4 papers). Christie Thomas collaborates with scholars based in United States, Australia and Spain. Christie Thomas's co-authors include Walter Ling, Maureen Hillhouse, Andrew J. Saxon, Paul McLaughlin, Allan Cohen, Petra Jacobs, Katharina Wiest, Yih‐Ing Hser, Cheryl Teruya and Albert Hasson and has published in prestigious journals such as Addiction, Drug and Alcohol Dependence and Journal of Substance Abuse Treatment.

In The Last Decade

Christie Thomas

12 papers receiving 715 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial

2013 347 citations Yih‐Ing Hser, Andrew J. Saxon et al. Addiction profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christie Thomas United States	10	621	471	180	120	120	12	749
Johan Kakko Sweden	8	607 1.0×	382 0.8×	254 1.4×	114 0.9×	101 0.8×	12	815
Leif Grönbladh Sweden	10	456 0.7×	411 0.9×	141 0.8×	101 0.8×	90 0.8×	17	704
Michael Varenbut Canada	18	480 0.8×	392 0.8×	172 1.0×	133 1.1×	93 0.8×	29	867
Thomas Santo Australia	13	600 1.0×	494 1.0×	161 0.9×	81 0.7×	121 1.0×	25	839
Margaret Jarvis United States	7	595 1.0×	338 0.7×	289 1.6×	74 0.6×	127 1.1×	11	806
Zachary A. Kasper United States	12	621 1.0×	420 0.9×	216 1.2×	104 0.9×	164 1.4×	20	828
Katharina Wiest United States	12	833 1.3×	683 1.5×	275 1.5×	130 1.1×	154 1.3×	21	1.1k
Harald Eder Austria	14	608 1.0×	291 0.6×	331 1.8×	163 1.4×	77 0.6×	22	835
Jennifer Casarella United States	13	391 0.6×	270 0.6×	103 0.6×	80 0.7×	74 0.6×	17	600
Soraya Mayet United Kingdom	15	657 1.1×	564 1.2×	217 1.2×	101 0.8×	71 0.6×	25	984

Countries citing papers authored by Christie Thomas

Since Specialization

Citations

This map shows the geographic impact of Christie Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christie Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christie Thomas more than expected).

Fields of papers citing papers by Christie Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christie Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christie Thomas. The network helps show where Christie Thomas may publish in the future.

Co-authorship network of co-authors of Christie Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Christie Thomas. A scholar is included among the top collaborators of Christie Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christie Thomas. Christie Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Mooney, Larissa J., Maureen Hillhouse, Christie Thomas, et al.. (2016). Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. Journal of Addiction Medicine. 10(4). 236–243. 16 indexed citations

Oyama, Mark A., Maureen Hillhouse, Christie Thomas, et al.. (2015). Using cellphone technology to monitor and increase dosing adherence. Drug and Alcohol Dependence. 156. e168–e168. 2 indexed citations

Teruya, Cheryl, Robert P. Schwartz, Shannon Gwin Mitchell, et al.. (2014). Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. Journal of Psychoactive Drugs. 46(5). 412–426. 75 indexed citations

Hser, Yih‐Ing, Andrew J. Saxon, David Huang, et al.. (2013). Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial. Addiction. 109(1). 79–87. 347 indexed citations breakdown →

Nielsen, Suzanne, Maureen Hillhouse, Christie Thomas, Albert Hasson, & Walter Ling. (2012). A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. Journal of Addiction Medicine. 7(1). 33–38. 38 indexed citations

Mooney, Larissa J., Suzanne Nielsen, Andrew J. Saxon, et al.. (2012). Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology. Contemporary Clinical Trials. 34(2). 196–204. 15 indexed citations

Saxon, Andrew J., Walter Ling, Maureen Hillhouse, et al.. (2012). Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial. Drug and Alcohol Dependence. 128(1-2). 71–76. 83 indexed citations

Hillhouse, Maureen, et al.. (2011). Participant Characteristics and Buprenorphine Dose. The American Journal of Drug and Alcohol Abuse. 37(5). 453–459. 28 indexed citations

Ling, Walter, Petra Jacobs, Maureen Hillhouse, et al.. (2010). From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment. 38. S53–S60. 37 indexed citations

10.

Brown, E. Sherwood, Carlos Tirado, Abu Minhajuddin, et al.. (2010). Association of Race and Ethnicity With Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. Journal of Ethnicity in Substance Abuse. 9(2). 106–114. 12 indexed citations

11.

Ling, Walter, Maureen Hillhouse, Catherine P. Domier, et al.. (2009). Buprenorphine tapering schedule and illicit opioid use. Addiction. 104(2). 256–265. 95 indexed citations

12.

Ling, Walter, Maureen Hillhouse, Catherine P. Domier, et al.. (2009). LONG‐SUFFERING OR PROLONGED SUFFERING? TIME MATTERS. Addiction. 104(8). 1429–1430. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact